Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Zhou, Wen ^a   Feng, Xiangling ^a   Ren, Caiping ^a   Jiang, Xingjun ^b   Liu, Weidong ^a   Huang, Wei ^a   Liu, Zhihong ^c   Li, Zan ^c   Zeng, Liang ^c   Wang, Lei ^a   Zhu, Bin ^a   Shi, Jia ^a   Liu, Jie ^a   Zhang, Chang ^a   Liu, Yanyu ^a   Yao, Kaitai ^a,d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HUNAN CANCER HOSPITAL   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

BCAT1; c Myc; Gene amplification; Gene regulation; Invasion; Migration; Nasopharyngeal carcinoma; Proliferation

Indexed keywords

BCAT1 PROTEIN; DNA; LUCIFERASE; MESSENGER RNA; MYC PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROSATELLITE MARKER; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; EXONS; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MUTATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MYC; TRANSAMINASES; TUMOR STEM CELL ASSAY;

EID: 84878636417     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-53     Document Type: Article

References (39)

1. Yao KT. The application and prospect of nasopharyngeal carcinoma etiology. China Cancer 1997, 6(7):3-4.
2. Yung WC, Sham JS, Choy DT, Ng MH. ras mutations are uncommon in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 1995, 31B:399-400.
3. Lin HS, Berry GJ, Sun Z, Fee WE. Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 2006, 4:62. 10.1186/1477-7819-4-62, 1569377, 16953893.
4. Wu HC, Lu TY, Lee JJ, Hwang JK, Lin YJ, Wang CK, Lin CT. MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest 2004, 84:1547-1556. 10.1038/labinvest.3700183, 15448710.
5. Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH, et al. Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. Int J Oncol 2002, 21:1197-1204.
6. Leong JL, Loh KS, Putti TC, Goh BC, Tan LK. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 2004, 114:153-157. 10.1097/00005537-200401000-00029, 14710013.
7. Porter MJ, Field JK, Lee JC, Leung SF, Lo D, Van Hasselt CA. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 1994, 14:1357-1360.
8. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Satake K, Koshika S, Nakatani Y, Hara M, Kato Y, Nagashima Y. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 2001, 25:414-419.
9. Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu W, Tao Q, Yao K. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 2005, 7:809-815. 10.1593/neo.05217, 1501935, 16229803.
10. Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai) 2006, 38:349-355.
11. Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res 2006, 16:261-272.
12. Zhang H, Feng X, Liu W, Jiang X, Shan W, Huang C, Yi H, Zhu B, Zhou W, Wang L, et al. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines. J Cell Biochem 2011, 112:1832-1843. 10.1002/jcb.23101, 21400573.
13. Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 2007, 46:171-180. 10.1002/gcc.20398, 17099870.
14. Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 2004, 112:628-635. 10.1002/ijc.20454, 15382043.
15. Huang Z, Desper R, Schaffer AA, Yin Z, Li X, Yao K. Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer 2004, 40:307-315. 10.1002/gcc.20036, 15188453.
16. Zhou W, Feng X, Li H, Wang L, Zhu B, Zhang H, Yao K, Ren C. Functional evidence for a nasopharyngeal carcinoma-related gene BCAT1 located at 12p12. Oncol Res 2007, 16:405-413.
17. Ben-Yosef T, Yanuka O, Halle D, Benvenisty N. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene 1998, 17:165-171. 10.1038/sj.onc.1201939, 9674700.
18. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005, 37:S11-S17. 10.1038/ng1569, 15920524.
19. Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007, 9:1-24.
20. Bledsoe RK, Dawson PA, Hutson SM. Cloning of the rat and human mitochondrial branched chain aminotransferases (BCATm). Biochim Biophys Acta 1997, 1339:9-13. 10.1016/S0167-4838(97)00044-7, 9165094.
21. Eden A, Simchen G, Benvenisty N. Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J Biol Chem 1996, 271:20242-20245. 10.1074/jbc.271.34.20242, 8702755.
22. Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N. ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc Natl Acad Sci USA 1996, 93:7143-7148. 10.1073/pnas.93.14.7143, 38950, 8692959.
23. Eden A, Benvenisty N. Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. FEBS Lett 1999, 457:255-261. 10.1016/S0014-5793(99)01054-6, 10471790.
24. Rodriguez S, Jafer O, Goker H, Summersgill B, Zafarana G, Gillis AJ, van Gurp RJ, Oosterhuis JW, Lu YJ, Huddart R, et al. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 2003, 22:1880-1891. 10.1038/sj.onc.1206302, 12660824.
25. Ben-Yosef T, Eden A, Benvenisty N. Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2. Mamm Genome 1998, 9:595-597. 10.1007/s003359900825, 9657861.
26. Weggen S, Preuss U, Pietsch T, Hilger N, Klawitz I, Scheidtmann KH, Wiestler OD, Bayer TA. Identification of amplified genes from SV40 large T antigen-induced rat PNET cell lines by subtractive cDNA analysis and radiation hybrid mapping. Oncogene 2001, 20:2023-2031. 10.1038/sj.onc.1204287, 11360186.
27. Rodenhuis S, Slebos RJ. The ras oncogenes in human lung cancer. Am Rev Respir Dis 1990, 142:S27-30. 10.1164/ajrccm/142.6_Pt_2.S27, 2252272.
28. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 1997, 19:93-101. 10.1097/00043426-199703000-00001, 9149737.
29. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997, 15:2894-2904.
30. Sun D, Zhang Z, Van do N, Huang G, Ernberg I, Hu L. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol 2007, 43:82-87. 10.1016/j.oraloncology.2006.01.007, 16807071.
31. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, Huang DP. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 2000, 31:169-178. 10.1016/S0046-8177(00)80216-6, 10685630.
32. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010, 6:e1000940. 10.1371/journal.ppat.1000940, 2880580, 20532215.
33. Huang GW, Mo WN, Kuang GQ, Nong HT, Wei MY, Sunagawa M, Kosugi T. Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. Laryngoscope 2001, 111:1465-1471. 10.1097/00005537-200108000-00025, 11568585.
34. Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 2006, 66:9385. 10.1158/0008-5472.CAN-06-0590, 17018592.
35. Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, Wang LL, Liu HY, Zhou M, Tang YL, Li WS, et al. The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology 2006, 71:273-281. 10.1159/000106073, 17641538.
36. Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H, et al. ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol 2006, 12:5884-5889.
37. de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 2008, 10:648-660. 10.1215/15228517-2008-032, 2666242, 18577562.
38. Song LB, Yan J, Jian SW, Zhang L, Li MZ, Li D, Wang HM. [Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines]. Ai Zheng 2002, 21:158-162.
39. Wanggou S, Jiang X, Li Q, Zhang L, Liu D, Li G, Feng X, Liu W, Zhu B, Huang W, et al. HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma. J Neurooncol 2012, 106:251-259. 10.1007/s11060-011-0673-7, 21861197.